2010 Hong Kong Reference Framework for Hypertension Care for ...

More documents

Recommendations

Info

Module 7Drug Treatment for People with HypertensionReference:1. Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of differentblood-pressure-lowering regimens on major cardiovascular events: results of prospectivelydesignedoverviews of randomised trials. Lancet. 2003; 362(9395):1527-35.2. Cushman WC, Ford CE, Cutler JA, Margolis KL, Davis BR, Grimm RH, et al. Successand predictors of blood pressure control in diverse North American settings: TheAntihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).J Clin Hypertens (Greenwich). 2002;4(6):393-404.3. Black HR, Elliott WJ, Neaton JD, Grandits G, Grambsch P, Grimm RH, Jr., et al. BaselineCharacteristics and Early Blood Pressure Control in the CONVINCE Trial. Hypertension.2001; 37(1):12-8.4. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, andother blood-pressure-lowering drugs: results of prospectively designed overviews ofrandomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet.2000;356(9246):1955-64.5. U.S. Department of Health and Human Services. The seventh report of the Joint NationalCommittee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.[Internet]. Bethesda, MD: U.S. Department of Health and Human Services; 2004. Availablefrom: http://www.nhlbi.nih.gov/guidelines/hypertension/jnc7full.pdf6. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al. Cardiovascularmorbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertensionstudy (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003.7. Major outcomes in high-risk hypertensive patients randomized to angiotensin-convertingenzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-97.8. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensinconverting-enzymeinhibitor, ramipril, on cardiovascular events in high-risk patients.The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342(3):145-53.9. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressurelowering regimen among 6,105 individuals with previous stroke or transient ischaemicattack. Lancet. 2001;358(9287):1033-41.HK Reference Framework for Hypertension Care for Adults in Primary Care Settings6
Module 7Drug Treatment for People with Hypertension10. Wing LM, Reid CM, Ryan P, Beilin LJ, Brown MA, Jennings GL, et al. A comparison ofoutcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension inthe elderly. N Engl J Med. 2003; 348(7):583-92.11. Psaty BM, Smith NL, Siscovick DS, Koepsell TD, Weiss NS, Heckbert SR, et al. Healthoutcomes associated with antihypertensive therapies used as first-line agents. A systematicreview and meta-analysis. JAMA. 1997;277(9):739-45.12. National Collaborating Centre for Chronic Conditions. Hypertension: management in adultsin primary care: pharmacological update. London: Royal College of Physicians; 2006.Available from: http://www.nice.org.uk/nicemedia/live/10986/30111/30111.pdf13. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, andother blood-pressure-lowering drugs: results of prospectively designed overviews ofrandomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet.2000; 356(9246):1955-64.14. Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, et al. Principalresults of the Controlled Onset Verapamil Investigation of Cardiovascular End Points(CONVINCE) trial. JAMA. 2003;289(16):2073-82.15. Chan WK, Chung TS, Lau BS, Law HT, Yeung AK, Wong CH. Management ofhypertension by private doctors in Hong Kong. Hong Kong Med J. 2006;12(2):115-8.16. Sagnella GA. Why is plasma renin activity lower in populations of African origin? J HumHypertens. 2001;15(1):17-25.17. Gibbs CR, Beevers DG, Lip GY. The management of hypertensive disease in black patients.QJM. 1999;92(4):187-92.18. He FJ, Markandu ND, Sagnella GA, MacGregor GA. Importance of the renin system indetermining blood pressure fall with salt restriction in black and white hypertensives.Hypertension. 1998;32(5):820-4.19. MRC trial of treatment of mild hypertension: principal results. Medical Research CouncilWorking Party. Br Med J (Clin Res Ed). 1985;291(6488):97-104.20. Medical Research Council trial of treatment of hypertension in older adults: principalresults. MRC Working Party. BMJ. 1992;304(6824):405-12.7 HK Reference Framework for Hypertension Care for Adults in Primary Care Settings
Page 2:
ContentPreface.....................
Page 6 and 7:
Key To Evidence Statements And Grad
Page 8 and 9:
Chapter 1.EpidemiologyHypertension
Page 12 and 13:
Chapter 6.Component 1: Prevention O
Page 14 and 15:
Chapter 7.Component 2: Early Identi
Page 16 and 17:
Chapter 8.Component 3: Clinical Car
Page 18 and 19:
Chapter 8.Component 3: Clinical Car
Page 20 and 21: Chapter 8.Component 3: Clinical Car
Page 26 and 27: Chapter 9.Component 4: Patient Empo
Page 28 and 29: Appendix 1. Smoking Cessation Servi
Page 30 and 31: AcknowledgmentsDr CHU Leung-wingDr
Page 32 and 33: AcknowledgmentsDr CHAN Wai-manDr Jo
Page 34 and 35: AcknowledgmentsDr Betty YOUNG Wan-y
Page 36 and 37: AcknowledgmentsProfessor YU Cheuk-m
Page 38 and 39: Reference10. Sacks FM, Svetkey LP,
Page 40 and 41: Module 1 Framework for Population A
Page 42 and 43: Module 1Framework for Population Ap
Page 44 and 45: Module 2Blood Pressure Measurement2
Page 46 and 47: Module 2Blood Pressure Measurement4
Page 48 and 49: Module 3 Secondary Hypertension 1,2
Page 50 and 51: Module 4Evaluation for All Newly Di
Page 52 and 53: Module 4Evaluation for All Newly Di
Page 54 and 55: Module 5Dietary InterventionFood Gr
Page 56 and 57: Module 5Dietary InterventionMeals a
Page 58 and 59: Module 5Dietary InterventionReferen
Page 60 and 61: Module 6Exercise Recommendations to
Page 66 and 67: Module 7Drug Treatment for People w
Page 74 and 75: Module 8Annual AssessmentLaboratory
show all

2010 Hong Kong Reference Framework for Hypertension Care for ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?